“≥99% pure” is the marketing line. What does it actually mean — and what’s in the other 1%?
How Purity Is Measured
Peptide purity is most commonly reported as HPLC area % — the area under the target peak on a chromatogram divided by the total area of all detected peaks, expressed as a percentage.
It’s important to note this is not a measure of mass purity. It’s a measure of UV-detectable organic component purity at the wavelength used (usually 214 nm or 280 nm for peptides). Inorganic salts, water, and any impurity that doesn’t absorb UV at the detection wavelength won’t appear in the chromatogram and therefore don’t affect the purity number.
For most research peptide work, this is fine — UV-active impurities (other peptides, peptide fragments, racemized isomers) are exactly the contaminants that would interfere with biological assays. But it’s worth knowing that “99% HPLC pure” doesn’t mean “99% peptide by mass.” It means “99% of the UV signal is the target peptide.”
The Tiers
≥99% — Research-Grade Standard
The bar for serious research work. The 1% non-target signal is typically:
- Minor synthesis byproducts (incomplete coupling fragments, deletion sequences)
- Trace racemization at one or more amino acids (D-isomer instead of L-isomer)
- Trace truncation products (peptide minus one or two residues from either terminus)
For most research applications — receptor binding studies, in vitro enzymatic assays, animal model work — these trace impurities don’t affect outcomes. ≥99% is the sweet spot of cost vs. quality.
≥99.5% — Premium Grade
Achievable for shorter peptides (under 15 amino acids) and worth specifying when:
- The assay is sensitive to deletion sequences (e.g., kinetics studies where binding affinity differences are small)
- The protocol requires multi-week stability and you want the lowest starting impurity to maximize the effective stability window
- The peptide is being used as a reference standard for comparison work
For longer peptides (30+ amino acids), achieving 99.5% becomes economically prohibitive — the synthetic chemistry produces enough fragment diversity that pushing past 99% requires extensive HPLC purification rounds.
95–99% — Acceptable for Some Preliminary Work
Below 99% is no longer “research-grade” by the standard most published methods literature uses. The 1–5% non-target material is enough to interfere with sensitive assays.
That said, 95–99% has a legitimate use case: preliminary screening work where the goal is to identify whether a peptide does anything at all in a system, before committing to higher-cost research-grade material for definitive studies. Some pharmacology labs use 95%-grade peptides for the first round of dose-response experiments and then re-run at 99%+ for final reportable data.
Below 95% — Not Research-Grade
Below 95% should not be treated as research-grade regardless of price. The remaining 5%+ is unidentified material that is likely a mix of:
- Multiple deletion sequences and synthesis byproducts
- Unreacted protecting groups from the synthesis chemistry
- Larger truncation products
- In some cases, inorganic counter-ions from the purification step
Some “peptide products” sold below 95% are actually deliberately under-purified to lower the price point. They have a place in some industrial applications but they don’t have a place in research.
What’s Actually in the Impurity Fraction
For the typical 99% peptide, the 1% impurity breaks down approximately:
| Impurity Type | Typical % of Impurity Fraction | Origin |
|---|---|---|
| Deletion sequences | 30–50% | Synthesis errors during solid-phase coupling |
| Racemized residues | 15–30% | Heat or base exposure during synthesis |
| Truncations | 10–25% | Premature cleavage during deprotection |
| Oxidation products | 5–15% | Methionine, tryptophan, cysteine — exposure to air |
| Acetylation byproducts | 5–10% | Capping reactions during synthesis |
None of this is dangerous in a research context. It’s the natural byproduct of peptide chemistry. But knowing what’s in the impurity fraction helps you assess whether your specific assay is sensitive to it.
The Endotoxin Question
HPLC purity is one axis. Endotoxin contamination is a separate axis that pure organic chemistry purity doesn’t address.
Endotoxins are bacterial cell wall fragments (lipopolysaccharide) that can contaminate any peptide synthesis if the synthesis equipment, solvents, or post-synthesis handling introduce bacterial growth. Even at sub-ng/mL levels, endotoxins activate inflammatory pathways in cell-based assays — which can completely confound results in immunology, cytokine, or cell-stress research.
The standard endotoxin assay is the Limulus Amebocyte Lysate (LAL) test, reported in EU/mg or EU/mL.
- <0.5 EU/mg: low-endotoxin grade, suitable for cell culture and in vivo work
- 0.5–5 EU/mg: standard research grade, fine for most in vitro biochemistry
- 5–50 EU/mg: elevated; suitable only for non-cell-based work
- >50 EU/mg: high; not suitable for biological assays
A complete COA includes both HPLC purity AND an LAL endotoxin result. If a supplier publishes only purity, they’re hiding half the picture.
What Matte’s COAs Show
Every Matte Protocol COA includes:
- HPLC chromatogram with detected peaks, retention times, and area %
- Calculated purity (area % of target peak)
- Mass spectrometry confirmation of molecular weight (≤2 Da of theoretical)
- LAL endotoxin assay result in EU/mg
- Lot number, manufacture date, expiration date
- Compound identity and synthesized sequence
The full library is at matteprotocol.com/coas/, organized by lot number.
Research use only. The information in this article is intended for qualified researchers and does not constitute medical or veterinary advice. Statements have not been evaluated by the US FDA.